TD Asset Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

TD Asset Management’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-49,730	Closed	-$611K	–	1495
2022 Q4	$611K	Hold	49,730	–	–	﹤0.01%	1246
2022 Q3	$1.49M	Sell	49,730 -2,235	-4%	-$63.2K	﹤0.01%	1085
2022 Q2	$979K	Hold	51,965	–	–	﹤0.01%	1187
2022 Q1	$911K	Buy	+51,965	New	+$1.07M	﹤0.01%	1247

TD Asset Management's CINC Position: Q1 2023 in Review

TD Asset Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 49,730 shares — an estimated $611K sold.

TD Asset Management first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $1.49M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

TD Asset Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
TD Asset Management sold 49,730 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $611K.
TD Asset Management first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
TD Asset Management's CinCor Pharma, Inc. Common Stock position peaked at $1.49M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.